Epidemiologic Study of Hepatocellular Carcinoma in the US



Status:Recruiting
Conditions:Liver Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:35 - 84
Updated:4/21/2016
Start Date:April 2015
End Date:April 2020

Use our guide to learn which trials are right for you!

The purpose of this study is:

- to investigate the risk factors of HCC among Americans with focus on lifestyle factors
and energy balance.

- to identify single nucleotide polymorphisms (SNPs) and haplotypes that are associated
with HCC risk through a genome-wide search.

- to assess if genetic susceptibility differs by hepatitis virus infection or lifestyle
factors, and to explore if there are interplays or effect modifications between genetic
factors and viral infection or lifestyle factors.


Inclusion Criteria for HCC cases:

- a diagnosis of primary liver cancer (excluding secondary tumors)

- a diagnosis of hepatocellular carcinoma if histology is available (excluding those
diagnosed in intrahepatic bile duct, bile canals, biliary passages, canaliculi, gall
duct and gallbladder)

- a diagnosis of hepatocellular carcinoma with or without microscopic evaluation
(including those diagnosed with clinical evidence, lab tests and direct visualization
or radiographic and other imaging evidence)

- a histology of primary hepatocellular carcinoma when the patients had a prior
diagnosis of other forms of cancer (excluding those who had no histological diagnosis
of hepatocellular carcinoma while having a prior history of other cancer;

- age at diagnosis between 35 and 84 years

- living in Connecticut, New Jersey, New York, or Hawaii for at least a year as regular
residents.

Exclusion Criteria for HCC cases:

- uncertain diagnoses or classification of malignancy, such as unknown origin

- a diagnosis of primary tumors in other organs, not in the liver

- unable to communicate well enough in English or Spanish

- having medical conditions, such as mental disorders, that prevent the subject from
providing reasonably comprehensible information or from being able to give informed
consent.

- diagnosed at age <35 years or >84 years

- temporary residents of New Jersey, Connecticut, New York, or Hawaii

Inclusion Criteria for control subjects:

- age between 35 and 84 years

- living in New Jersey or Connecticut for at least a year as regular residents

- able to communicate well in English or Spanish

- having no medical conditions, such as mental disorders, that prevent them from
providing adequately comprehensible information

- potential subjects with a previous history of cancer are eligible.

Exclusion Criteria for control subjects:

- age < 35 years or > 84 years

- temporary residents of New Jersey or Connecticut

- unable to speak English or Spanish

- cannot provide adequately comprehensible information
We found this trial at
1
site
Stanford, California 94305
Principal Investigator: Mindie Nguyen, MD
?
mi
from
Stanford, CA
Click here to add this to my saved trials